Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306025 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Joo Hong Joun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Hyperuricemia, Molybdenum, Antioxidants, Oxidative Stress. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul Metropolitan Government Seoul National University Boramae Medical Center.
Abstract (Originalsprache)
The relationship between molybdenum and kidney-related disease outcomes, including hyperuricemia, is not well investigated. This study aims to determine whether molybdenum and its antioxidative property are associated with systemic inflammation and kidney-related disease parameters including hyperuricemia. Urinary molybdenum’s epidemiological relationship to hyperuricemia and kidney-disease related outcomes was evaluated in 15,370 adult participants in the National Health and Nutrition Examination Survey (NHANES) collected between 1999 and 2016. Individuals’ urinary molybdenum levels were corrected to their urinary creatinine concentrations. The association between urinary molybdenum-to-creatinine ratio and kidney-disease related outcomes were assessed by multivariable linear and logistic regression analyses, adjusting for covariates including age, sex, ethnicity, diabetes mellitus, hypertension, body mass index, and estimated glomerular filtration rate. Antimony and tungsten were used as control trace metals. Experimentally, HK-2 cell was used to assess molybdenum’s antioxidative properties. HK-2 cells were challenged with H 2 O 2 -induced oxidative stress. Oxidative stress was measured using a fluorescent microplate assay for reactive oxygen species (ROS) and antioxidation levels were assessed by measuring the expression of manganese superoxide dismutase. In the adult NHANES population, urinary molybdenum-to-creatinine ratio was significantly associated with decreased serum uric acid (β, -0.119; 95% CI, -0.148 to -0.090) concentrations, and decreased prevalence of hyperuricemia (OR, 0.73; 95% CI, 0.64–0.83) and gout (OR, 0.71; 95% CI, 0.52–0.94). Higher urinary molybdenum levels were associated with lower levels of systemic oxidative stress (gamma-glutamyltransferase levels; β, -0.052; 95% CI, -0.067 to -0.037) and inflammation (C-reactive protein levels; β, -0.184; 95% CI, -0.220 to -0.148). In HK-2 cells under H 2 O 2 -induced oxidative stress, molybdenum upregulated manganese superoxide dismutase expression and decreased oxidative stress. Urinary molybdenum levels are associated with decreased prevalence of hyperuricemia and gout in adult population. Molybdenum’s antioxidative properties might have acted as an important mechanism for the reduction of systemic inflammation, ROS, and uric acid levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Department of Intensive Care Unit, Yanbian University Hospital, Jilin, China.
- Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
- Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
ORCID-Profile: Yun Kyu Oh, Jeonghwan Lee
Förderung
- Seoul Metropolitan Government Seoul National University Boramae Medical Center
Zitieren
APA
Joun, J. H., Li, L., An, J. N., Jang, J., Oh, Y. K., Lim, C. S., Kim, Y. S., Choi, K., Lee, J. P., & Lee, J. (2024). Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population. PLOS ONE. https://doi.org/10.1371/journal.pone.0306025
Vancouver
Joun JH, Li L, An JN, Jang J, Oh YK, Lim CS, et al. Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population. PLOS ONE. 2024. doi:10.1371/journal.pone.0306025
BibTeX
@article{Joun2024,
author = {Joun, Joo Hong and Li, Lilin and An, Jung Nam and Jang, Joonho and Oh, Yun Kyu and Lim, Chun Soo and Kim, Yon Su and Choi, Kyungho and Lee, Jung Pyo and Lee, Jeonghwan},
title = {Antioxidative effects of molybdenum and its association with reduced prevalence of hyperuricemia in the adult population},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306025}
}
EUVIMED